Hunan Kelun Pharmaceutical Co., Ltd.
Clinical trials sponsored by Hunan Kelun Pharmaceutical Co., Ltd., explained in plain language.
-
New drug KLA578-1 tested in healthy people for first time
Knowledge-focused Recruiting nowThis early-stage study tests the safety and how the body handles a new drug called KLA578-1. About 48 healthy adults aged 18-45 will receive single or multiple doses. The goal is to check for side effects and measure drug levels in the blood, not to treat any disease.
Phase: PHASE1 • Sponsor: Hunan Kelun Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 04:37 UTC
-
New drug injection tested in healthy people – no cure expected
Knowledge-focused Recruiting nowThis early-stage study tests a new injection called KLA318-2 in 48 healthy adults aged 18 to 45. The main goal is to check if it is safe and how the body processes it. Participants receive a single dose and are monitored for side effects and drug levels in the blood. This study d…
Phase: PHASE1 • Sponsor: Hunan Kelun Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 04:33 UTC
-
New drug KLA478 enters first human safety tests
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug, KLA478, in 40 healthy adults aged 18 to 45. The main goal is to see if the drug is safe and how the body processes it. Participants receive a single dose and are monitored for side effects and drug levels in the blood. This study does…
Phase: PHASE1 • Sponsor: Hunan Kelun Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 04:17 UTC